School of Medicine
Showing 8,151-8,200 of 12,898 Results
-
Ryan Nitta
Senior Research Scientist, Neurosurgery
Current Role at StanfordThe main project of the Li lab is to elucidate the signaling pathways responsible for maintaining and initiating brain tumor growth. Previously the Li lab has identified an interesting protein, known as casein kinase 2, which plays an integral role in adult brain tumor growth. My goal is to expand on this initial finding and determine if casein kinase 2 could be a therapeutically relevant drug target in adult brain tumors and whether this protein plays a role in pediatric brain tumors. The role of the candidate would be the lead researcher on these projects, as well as managing and leading the undergraduate and medical students in the lab. In addition, I am responsible for maintaining the laboratory and assisting in grant writing.
-
Joyce Njoroge, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Njoroge is a board-certified physician and fellowship-trained cardiologist with the Advanced Heart Failure Program at Stanford Health Care. She is also a clinical assistant professor of medicine in the Division of Cardiovascular Medicine.
Dr. Njoroge has extensive clinical experience diagnosing and treating cardiovascular complications that develop during pregnancy or postpartum. She currently provides care at the Stanford Health Care Heart and Vascular Clinic with a particular focus on patients with a history of pregnancy-associated heart failure and cardiomyopathy.
Dr. Njoroge’s research efforts involve identifying inherited genetic changes and biological markers that could help improve screening and care for pregnant women in higher risk populations. This includes determining the causes of disproportionately high incidences of heart-related complications and deaths experienced by Black women during and after pregnancy. Dr. Njoroge is also currently recruiting patients for a large-scale, multicenter clinical trial evaluating a drug to treat cardiovascular complications during pregnancy.
Dr. Njoroge has published her work in numerous prestigious peer-reviewed journals, including Circulation Research and the Journal of Cardiac Failure. She also co-authored a chapter on cardiovascular disease in pregnancy in the most recent edition of the book Current Diagnosis and Treatment: Cardiology.
Dr. Njoroge is a member of the Association of Black Cardiologists, the American College of Cardiology, the American Heart Association, and the Heart Failure Society of America. -
Chloe Nobuhara
Masters Student in Epidemiology and Clinical Research, admitted Autumn 2025
BioChloe Nobuhara is a fourth year general surgery resident at Stanford University, currently doing two years of research in the application of artificial intelligence in the operating room. Her projects include computer vision pipelines for automated performance assessment, the use of ambient intelligence for operational efficiency, and the use of automated documentation for burnout reduction. She completed her undergraduate studies at Northeastern University and her MD at Duke University School of Medicine. She is also concurrently in a Masters in Epidemiology with a focus in informatics.
-
Julia E. Noel, MD
Clinical Assistant Professor (Affiliated), OHNS/Head & Neck Surgery Divisions
Staff, OHNS/Otolaryngology/Head & Neck SurgeryBioDr. Noel is a head and neck surgeon with fellowship training in endocrine surgery, specializing in surgery of the thyroid and parathyroid gland and lymph nodes. She is the chief of Otolaryngology Head & Neck Surgery at Santa Clara Valley Medical Center and an affiliate assistant professor in the Stanford School of Medicine.
Among the many conditions she treats are thyroid cancer, thyroid nodules, hyperthyroidism, hyperparathyroidism, hypercalcemia, Grave’s disease, and goiter. She has expertise and training in minimally invasive treatment approaches and ultrasound-guided techniques performed in the office, such as radiofrequency ablation (RFA) and alcohol ablation.
For every patient, Dr. Noel prepares a personalized care plan that is comprehensive and compassionate. Her goal is to educate and empower each patient to achieve the best possible health and quality of life. Patient reviews praise her clinical expertise as well as her skills as a listener and communicator.
Dr. Noel conducts a robust research program to advance patient care. She has published extensively on the diagnosis, appropriate management, and optimization of outcomes for patients with thyroid and parathyroid disorders. Her articles have appeared in JAMA Otolaryngology Head and Neck Surgery, Nature Communications, Endocrine Practice, and many more peer-reviewed journals. She has co-authored numerous guideline and consensus statements, including an international statement on the use of RFA in benign and malignant thyroid nodules. She is an editorial board member for VideoEndocrinology, a video journal covering leading-edge diagnostic and treatment techniques and technologies, and has served as an associate editor for Laryngoscope Investigative Otolaryngology.
Dr. Noel has made presentations to her peers at national and international meetings of the American Academy of Otolaryngology, Head & Neck Surgery, American Thyroid Association, American Head & Neck Society, and the World Congress of Thyroid Cancer. She also has shared her insights into the future of thyroid surgery at the International Thyroid Cancer Survivors’ Conference.
She is a member of the American Academy of Otolaryngology and Head and Neck Surgery, American Head and Neck Society, American Thyroid Association, American College of Surgeons, and the North American Society for Interventional Thyroidology, of which she has served on the executive council since 2023. -
Chikage Noishiki, MD, PhD
Instructor, Cardiovascular Institute
BioDoctor of Philosophy, Nippon Medical School, Tokyo, Japan (2019)
Doctor of Medicine, Dokkyo university, Tochigi, Japan (2010)
Board Certified in Plastic and Reconstructive Surgery, Japan (2020)
Fellowship, Plastic and Reconstructive Surgery, Nippon Medical School, Tokyo, Japan (2016) -
Garry Nolan
Rachford and Carlota Harris Professor
Current Research and Scholarly InterestsDr. Nolan's group uses high throughput single cell analysis technology cellular biochemistry to study autoimmunity, cancer, virology (influenza & Ebola), as well as understanding normal immune system function. Using advanced flow cytometric techniques such as Mass Cytometry, MIBI (ion beam imaging), CODEX and computational biology approaches, we focus on understanding disease processes at the single cell level. We have a strong interest in cancer immunotherapy and pathogen-host interactions.
-
Humaira Noor
Postdoctoral Scholar, Biomedical Informatics
BioDr. Humaira Noor is a postdoctoral researcher in the Gevaert Lab with a PhD in glioma genomics from University of New South Wales, Australia. Her expertise spans biomarker discovery, with particular emphasis on prognostic and molecular determinants of glioma treatment-response, radiogenomic model development for early high-risk patient stratification, and the integration of multi-omics and biomedical imaging to advance precision oncology
-
Douglas Noordsy
Clinical Professor, Psychiatry and Behavioral Sciences
BioDouglas L. Noordsy, MD, is Clinical Professor, Director of Lifestyle Psychiatry and co-founder of the Sports Psychology & Psychiatry clinic in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. Dr. Noordsy was previously Professor of Psychiatry at the Geisel School of Medicine at Dartmouth. His research interests include effects of physical exercise on neurotrophic factors, brain volume and function and mental health and wellbeing. He is particularly interested in the role of physical exercise for prevention of progression of early psychosis and interactions between social and physical aspects of team sports. Dr. Noordsy is a member of the American College of Psychiatry, American College of Lifestyle Medicine and is a Distinguished Fellow of the American Psychiatric Association. He is a member of the editorial boards for Community Mental Health Journal and Mental Health & Physical Activity. Dr. Noordsy was recognized with the Exemplary Psychiatrist Award from the National Alliance on Mental Illness in 2001, and the Excellence in Leadership Award from the Department of Psychiatry & Behavioral Sciences at Stanford in 2018. He launched the Stanford Lifestyle & Sports Psychiatry Special Initiative of the Department of Psychiatry in 2024 and is seeking philanthropic partners.
https://med.stanford.edu/psychiatry/special-initiatives/lifestyle.html
https://med.stanford.edu/psychiatry/patient_care/lifestyle.html -
Anthony Norcia
Professor (Research) of Psychology, Emeritus
Current Research and Scholarly InterestsVision, development, functional imaging, systems analysis
-
Kristin M. Nord, MD
Clinical Professor, Dermatology
BioKristin M. Nord, M.D., is a Clinical Professor of Dermatology and served as Residency Program Director from 2012-2022. Dr. Nord received her doctor of medicine from the Columbia University College of Physicians and Surgeons, and completed her residency in Dermatology at New York Presbyterian-Columbia University Medical Center. Dr. Nord is Attending Physician at the VA Palo Alto Health Care System, where her clinical interests are general dermatology, complex medical dermatology and procedural dermatology, and she serves as Assistant Co-Chief of Dermatologic Surgery. Her research focus is on skin cancer education and prevention, and she is co-faculty lead for SUNSPORT (Stanford University Sun Protection Outreach Research and Teamwork).
-
Justin Norden, MD, MBA, MPhil
Affiliate, School of Medicine - Biomedical Ethics
BioDr. Justin Norden is an Adjunct Professor at Stanford Medicine in the Department of Biomedical Informatics Research. He teaches courses on digital health and AI in Medicine. His research focuses on AI in healthcare, digital health, and care system transformation.
Additionally, Dr. Norden is a Partner at GSR Ventures where he focuses on early-stage investments in digital health and AI/ML in healthcare. Prior to GSR Ventures, Dr. Norden was founder and CEO of Trustworthy AI which was acquired by Waymo (Google Self-Driving). He worked on the healthcare team at Apple, co-founded Indicator (an NLP based platform for biopharma decision making), and helped start the Stanford Center for Digital Health.
Dr. Norden received an MD from Stanford University School of Medicine, where he served as student body president. An MBA from the Stanford Graduate School of Business, where he served as president of the healthcare club. An M.Phil in Computational Biology with distinction from the University of Cambridge, and a BA in Computer Science with distinction from Carleton College.
Finally, he is a professional athlete for the Oakland Spiders (ultimate frisbee) - holding the team all-time records for assists and completions. He is a 3x World Champion, 1x professional champion, former Team USA Captain (U24), and D1 University National Champion. -
Amir Norouzpour
Basic Life Research Scientist, Ophthalmology Research/Clinical Trials
Current Role at StanfordResearch Scientist
-
Robert L Norris Jr
Professor of Emergency Medicine at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsEnvironmental toxinology, with special emphasis on envenomations (particularly snake venom poisoning; Airway management techniques; Tactical medicine
-
Jeffrey Norton, MD
Robert L. and Mary Ellenburg Professor of Surgery, Emeritus
Current Research and Scholarly InterestsInterleukin-12 is a Th1 cytokine. It is important in the cell mediated immune response. We are investigating its role as an anti-tumor cytokine to augment the immune response against cancer. We are planning a human trial.
-
Roberto Novoa, MD
Clinical Professor, Pathology
Clinical Professor, DermatologyCurrent Research and Scholarly InterestsMy research interests include the medical applications of artificial intelligence, cutaneous lymphoma, and the side effects of targeted therapies. I have served as the lead dermatologist in our ongoing effort to develop AI-augmented classification of skin lesions. We are in the process of establishing one of the first prospective studies examining the performance of a deep learning algorithm in real-world patients.
